Vaxcyte, Inc 10-Q for FY2020 Q3

Headline figures

Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss

$21.02M

compared with a net loss of $11.32M a year earlier